HSA4A Signs Partnership Agreement to Address Sexual and Reproductive Health and Rights in East Africa

by THE HSA4A PARTNERSHIP

Maternal mortality is the number one cause of death in sub-Saharan Africa. Despite the fact that maternal mortality is high on the international agenda, the goal to reduce maternal mortality by 75 percent by 2015, is still far from being reached. By advocating and influencing the availability of affordable medicines and contraception and increasing the availability and accessibility of skilled health workers,  

HAI Holds Workshops on EU Medicines Policy & Access to Medicines in Eastern Europe

by BOBBI KLETTKE, Communications

Access to medicines is a key component of the human right to health. Although the European Union (EU) and its Member States are committed to universal and equitable access to healthcare, many patients across Europe still suffer inequalities in medicines availability and affordability. This is particularly the case in Eastern European countries.

Can the WHO Set the Right Course for Antibiotics?

by MATTHEW ENEVOLDSON, Communications Intern

As a typically awkward teenager, I was, as many are, occasionally afflicted by an outbreak of spots. Whilst these were embarrassing, they were by no means terrible. Even at their worst, they were nothing but a shadow of those of the kid, resident in every school, who is plagued by acne.

HAI urges MEPs to support key amendments to TTIP resolution

by TESSEL MELLEMA and ALIÉNOR DEVALIÈRE, EU Policy Advisors

(UPDATE at 5:15 p.m. on 9 June: The European Parliament vote on TTIP has been postponed to a later date.)

It’s going to be a big day in Strasbourg tomorrow (10 June) as Members of the European Parliament vote on the Transatlantic Trade and Investment Partnership (TTIP) resolution.

Successful week of advocacy for HAI delegation at 68th World Health Assembly

by TIM REED, Executive Director

Health Action International’s largest-ever team to the 68th World Health Assembly enjoyed a fruitful week of advocacy, which resulted in some major achievements, particularly related to antimicrobial resistance and World Health Organization (WHO) engagement with non-state actors. The annual Assembly was held in Geneva from 18-26 May.

The delegation was comprised of 39 insightful and talented people from ReAct–Action on Antibiotic Resistance,

The EU-US Trade Deal Could Leave Europeans Sick

by TESSEL MELLEMA and ALIÉNOR DEVALIÈRE
 
Some help us for a while. Some cure us entirely. No doubt, medicines—when they’re available and affordable—play a crucial role in helping us live better quality and longer lives than ever before. So, why, then, would the European Commission do anything that would risk citizens’ ability to access the medicines we need?

World Health Assembly Executive Board 136: YP-CDN, NWIA and HAI intervention on the WHO’s internship programme

4 February 2015 | by TIM REED
 
At the 136th World Health Organization (WHO) Executive Board meeting in Geneva this past week, we had the privilege of developing an intervention with the Young Professionals Chronic Disease Network (YP-CDN) and the Network of WHO Intern Alumni (NWIA) regarding the WHO’s internships programme.

World Health Assembly Executive Board 136: YP-CDN and HAI intervention on the progress achieved in the prevention and control of non-communicable diseases

by KAVITHA KOLAPPA (Young Professionals Chronic Disease Network) and TIM REED (HAI)

Thank you Chair and esteemed delegates:
I am speaking on behalf of Health Action International and the Young Professionals Chronic Disease Network.
At last year’s Executive Board meeting, we heard an impassioned plea from South Africa whose draft reforms to their domestic intellectual property policy were under threat by a lobbying firm who planned a subversive campaign to block these reforms,

START TYPING AND PRESS ENTER TO SEARCH